Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Cancer Institute
Research
AACR: NCI leader assures researchers that ‘funding is strong’
NCI Director Letai envisions a return to normalcy for cancer research funding after last year's turmoil.
Darren Incorvaia
Apr 22, 2026 10:00am
GSK chief steps down in stunning move—Chutes & Ladders
Oct 3, 2025 8:30am
White House pledges $100M to AI pediatric cancer project
Oct 1, 2025 11:06am
Dana-Farber oncologist Anthony Letai tapped to direct NCI
Sep 30, 2025 5:50am
Senate bill aims to keep NIH, CDC funds intact
Aug 4, 2025 11:30am
Senators grill NIH chief over proposed $18B cut
Jun 10, 2025 5:21pm
